Okupe Oluyemi 4

What Happened

• Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, exercised 7,950 stock options and acquired 7,950 common shares at an exercise price of $5.01 per share (cost $39,830). On the same day (2026-05-18) he sold those 7,950 shares in an open-market transaction for a weighted average price of $23.64 per share, generating proceeds of about $187,916. A separate derivative line at $0.00 reflects the conversion/exercise of the option into shares.

Key Details

• Transaction dates: 2026-05-18 (exercise and sale). Filing date: 2026-05-19 (filed the next day).
• Exercise: 7,950 shares at $5.01 = $39,830 (code M).
• Sale: 7,950 shares at weighted avg $23.64 = $187,916 (code S); sale prices ranged $23.55–$23.80 per footnote.
• Net proceeds before taxes/fees: roughly $148,086 (sale proceeds minus exercise cost).
• Shares owned after transaction: not disclosed in this Form 4.
• Footnotes: transactions were executed under a Rule 10b5-1 trading plan adopted May 21, 2025; options were fully vested; weighted-average sale price disclosed with per-price breakdown available on request.
• Timeliness: filing appears timely (reported the day after the transactions).

Context

• This was an option exercise followed by an immediate sale (a common cashless-style outcome), executed under a pre-established 10b5-1 plan — which indicates the trades were pre-planned rather than spontaneous. Such sales are typically routine and do not by themselves indicate management’s ongoing view of the company.